Gold futures settled lower to a second straight session on Thursday, with the continued risk appetite in the market in midst of optimism that US FDA will approve emergency use of COVID vaccine in US. However, gains remained trimmed with the hopes on additional US fiscal stimulus measures ahead to the Federal Open Market Committee meeting next week.
Gold futures for February delivery dipped by 0.1% or $1.10 to settle at $1837.40 an ounce on the Comex division of the New York Mercantile. Spot gold rose fell 0.2% to $1,836.01 per ounce.